Royston Park, Australia

Ravi Krishnan

This inventor holds 14 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Polysaccharide Treatments. Top assignees: Mesoblast, Inc, Paradigm Biopharmaceuticals Ltd. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ravi Krishnan. Retrieved from https://idiyas.com/inventor/ravi-krishnan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Polysulfated Polysaccharides
Acute Respiratory Disease
Bone Marrow Pathologies
Pain Treatment
Osteoblastic Function
Obesity
Metabolic Syndrome
Post-Operative Pain
Diabetic Renal Failure
Pancreatic Dysfunction
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Ravi Krishnan

Introduction

Ravi Krishnan is a notable inventor based in Royston Park, Australia. He has made significant contributions to the field of medical science, particularly in the treatment of acute respiratory diseases and bone marrow pathologies. With a total of 14 patents to his name, his work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on the treatment of acute respiratory disease syndrome (ARDS) with polysulfated polysaccharides. This invention provides methods for treating ARDS, especially those caused by viral infections such as influenza and SARS-CoV-2. The methods include the administration of pentosan polysulfate (PPS) and sodium pentosan polysulfate, with prophylactic approaches that involve intra-nasal administration to inactivate the virus responsible for ARDS. Another significant patent addresses the treatment of bone marrow pathologies using polysulfated polysaccharides. This invention relates to the medical use of these compounds for disorders associated with bone marrow pathologies in the musculoskeletal system. It particularly focuses on the treatment of bone marrow edema lesions and spinal Modic Endplate Changes, as assessed by magnetic resonance imaging (MRI).

Career Highlights

Ravi Krishnan has worked with prominent companies in the biopharmaceutical sector, including Mesoblast, Inc. and Paradigm Biopharmaceuticals Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Ravi has collaborated with notable professionals in his field, including Silviu Itescu and Paul Rennie. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Ravi Krishnan's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancements. His contributions are poised to make a lasting impact on the treatment of serious medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…